496 related articles for article (PubMed ID: 25183657)
1. Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD.
Stubbs JR; Zhang S; Friedman PA; Nolin TD
Clin J Am Soc Nephrol; 2014 Nov; 9(11):1965-73. PubMed ID: 25183657
[TBL] [Abstract][Full Text] [Related]
2. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.
Wetmore JB; Kimber C; Mahnken JD; Stubbs JR
Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190
[TBL] [Abstract][Full Text] [Related]
3. Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials.
de Boer IH; Sachs MC; Chonchol M; Himmelfarb J; Hoofnagle AN; Ix JH; Kremsdorf RA; Lin YS; Mehrotra R; Robinson-Cohen C; Siscovick DS; Steffes MW; Thummel KE; Tracy RP; Wang Z; Kestenbaum B
Am J Kidney Dis; 2014 Aug; 64(2):187-97. PubMed ID: 24703961
[TBL] [Abstract][Full Text] [Related]
4. Serum 24,25-dihydroxyvitamin D
Graeff-Armas LA; Kaufmann M; Lyden E; Jones G
Clin Nutr; 2018 Jun; 37(3):1041-1045. PubMed ID: 28506446
[TBL] [Abstract][Full Text] [Related]
5. Effects of Vitamin D
Batacchi Z; Robinson-Cohen C; Hoofnagle AN; Isakova T; Kestenbaum B; Martin KJ; Wolf MS; de Boer IH
Clin J Am Soc Nephrol; 2017 Sep; 12(9):1498-1506. PubMed ID: 28768705
[TBL] [Abstract][Full Text] [Related]
6. Effect of Cholecalciferol therapy on serum FGF
Kamelian T; Saki F; Jeddi M; Dabbaghmanesh MH; Omrani GHR
J Endocrinol Invest; 2018 Mar; 41(3):299-306. PubMed ID: 28795342
[TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in response to vitamin D2 and vitamin D3 supplementation.
Biancuzzo RM; Clarke N; Reitz RE; Travison TG; Holick MF
J Clin Endocrinol Metab; 2013 Mar; 98(3):973-9. PubMed ID: 23386645
[TBL] [Abstract][Full Text] [Related]
8. Differential Effects of Oral Boluses of Vitamin D2 vs Vitamin D3 on Vitamin D Metabolism: A Randomized Controlled Trial.
Martineau AR; Thummel KE; Wang Z; Jolliffe DA; Boucher BJ; Griffin SJ; Forouhi NG; Hitman GA
J Clin Endocrinol Metab; 2019 Dec; 104(12):5831-5839. PubMed ID: 31199458
[TBL] [Abstract][Full Text] [Related]
9. High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial.
Alvarez JA; Law J; Coakley KE; Zughaier SM; Hao L; Shahid Salles K; Wasse H; Gutiérrez OM; Ziegler TR; Tangpricha V
Am J Clin Nutr; 2012 Sep; 96(3):672-9. PubMed ID: 22854402
[TBL] [Abstract][Full Text] [Related]
10. Regulation of fibroblast growth factor-23 in chronic kidney disease.
Westerberg PA; Linde T; Wikström B; Ljunggren O; Stridsberg M; Larsson TE
Nephrol Dial Transplant; 2007 Nov; 22(11):3202-7. PubMed ID: 17567652
[TBL] [Abstract][Full Text] [Related]
11. Plasma vitamin D metabolite concentrations in chronic renal failure: effect of oral administration of 25-hydroxyvitamin D3.
Halloran BP; Schaefer P; Lifschitz M; Levens M; Goldsmith RS
J Clin Endocrinol Metab; 1984 Dec; 59(6):1063-9. PubMed ID: 6333430
[TBL] [Abstract][Full Text] [Related]
12. Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation.
Petkovich M; Melnick J; White J; Tabash S; Strugnell S; Bishop CW
J Steroid Biochem Mol Biol; 2015 Apr; 148():283-9. PubMed ID: 25446887
[TBL] [Abstract][Full Text] [Related]
13. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D Metabolism Is Dysregulated in Asthma and Chronic Obstructive Pulmonary Disease.
Jolliffe DA; Stefanidis C; Wang Z; Kermani NZ; Dimitrov V; White JH; McDonough JE; Janssens W; Pfeffer P; Griffiths CJ; Bush A; Guo Y; Christenson S; Adcock IM; Chung KF; Thummel KE; Martineau AR
Am J Respir Crit Care Med; 2020 Aug; 202(3):371-382. PubMed ID: 32186892
[No Abstract] [Full Text] [Related]
15. Activation of FGF-23 mediated vitamin D degradative pathways by cholecalciferol.
Alshayeb H; Showkat A; Wall BM; Gyamlani GG; David V; Quarles LD
J Clin Endocrinol Metab; 2014 Oct; 99(10):E1830-7. PubMed ID: 24960544
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D Status in Chronic Kidney Disease - UVB Irradiation Is Superior to Oral Supplementation.
Krause R; Roth HJ; Kaase H; Stange R; Holick MF
Anticancer Res; 2016 Mar; 36(3):1397-401. PubMed ID: 26977042
[TBL] [Abstract][Full Text] [Related]
17. Placental vitamin D metabolism and its associations with circulating vitamin D metabolites in pregnant women.
Park H; Wood MR; Malysheva OV; Jones S; Mehta S; Brannon PM; Caudill MA
Am J Clin Nutr; 2017 Dec; 106(6):1439-1448. PubMed ID: 29021285
[No Abstract] [Full Text] [Related]
18. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study.
Chandra P; Binongo JN; Ziegler TR; Schlanger LE; Wang W; Someren JT; Tangpricha V
Endocr Pract; 2008; 14(1):10-7. PubMed ID: 18238736
[TBL] [Abstract][Full Text] [Related]
19. Cholecalciferol, Calcitriol, and Vascular Function in CKD: A Randomized, Double-Blind Trial.
Kendrick J; Andrews E; You Z; Moreau K; Nowak KL; Farmer-Bailey H; Seals DR; Chonchol M
Clin J Am Soc Nephrol; 2017 Sep; 12(9):1438-1446. PubMed ID: 28784657
[TBL] [Abstract][Full Text] [Related]
20. Dose-response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites: A randomized controlled trial in older adults.
Vaes AMM; Tieland M; de Regt MF; Wittwer J; van Loon LJC; de Groot LCPGM
Clin Nutr; 2018 Jun; 37(3):808-814. PubMed ID: 28433267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
